Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ATNM Relative to the S&P 500

ATNM Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Actinium Pharmaceuticals, Inc. (AMEX:ATNM) seasonal charts above shows that a Buy Date of December 14 and a Sell Date of April 12 has resulted in a geometric average return of 27.32% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 45.49% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.

To download ATNM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ATNM